BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27000128)

  • 1. Obturator Canal Lymph Node Metastasis from Rectal Carcinoid Tumors: Total Mesorectal Excision May Be Insufficient.
    Wang YZ; Beyer DT; Hall M
    J Gastrointest Surg; 2016 Jun; 20(6):1247-52. PubMed ID: 27000128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors.
    Ngamruengphong S; Kamal A; Akshintala V; Hajiyeva G; Hanada Y; Chen YI; Sanaei O; Fluxa D; Haito Chavez Y; Kumbhari V; Singh VK; Lennon AM; Canto MI; Khashab MA
    Gastrointest Endosc; 2019 Mar; 89(3):602-606. PubMed ID: 30447216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transanal lateral lymph node dissection surgery for 5 cases of mid-low rectal cancer].
    Zeng ZW; Zhang XW; Chen JJ; Huang L; Luo SL; Kang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):781-785. PubMed ID: 31422618
    [No Abstract]   [Full Text] [Related]  

  • 6. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
    Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
    World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic lateral pelvic lymph node dissection is achievable and offers advantages as a minimally invasive surgery over the open approach.
    Nagayoshi K; Ueki T; Manabe T; Moriyama T; Yanai K; Oda Y; Tanaka M
    Surg Endosc; 2016 May; 30(5):1938-47. PubMed ID: 26275538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of metastasis to mesorectal, internal iliac and obturator lymph nodes according to size criteria in patients with locally advanced lower rectal cancer.
    Hatano S; Ishida H; Ishiguro T; Kumamoto K; Ishibashi K; Mochiki E; Tamaru J
    Jpn J Clin Oncol; 2015 Jan; 45(1):35-42. PubMed ID: 25324477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph-node metastases in rectal carcinoids.
    Fujimoto Y; Oya M; Kuroyanagi H; Ueno M; Akiyoshi T; Yamaguchi T; Muto T
    Langenbecks Arch Surg; 2010 Feb; 395(2):139-42. PubMed ID: 19048280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective.
    Choi SH; Chang JS; Yoon HI; Jang DS; Kim NK; Lim JS; Min BS; Huh H; Shin SJ; Ahn JB; Koom WS
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1119-1128. PubMed ID: 29546480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploratory analysis of lateral pelvic sentinel lymph node status for optimal management of laparoscopic lateral lymph node dissection in advanced lower rectal cancer without suspected lateral lymph node metastasis.
    Yasui M; Ohue M; Noura S; Miyoshi N; Takahashi Y; Matsuda C; Nishimura J; Haraguchi N; Ushigome H; Nakai N; Fujino S; Sugimura K; Wada H; Takahashi H; Omori T; Miyata H
    BMC Cancer; 2021 Aug; 21(1):911. PubMed ID: 34380428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer.
    Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y
    Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoid tumors of the rectum: a multi-institutional international collaboration.
    Shields CJ; Tiret E; Winter DC;
    Ann Surg; 2010 Nov; 252(5):750-5. PubMed ID: 21037430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes after surgical dissection of inguinal lymph node metastasis from rectal or anal canal adenocarcinoma.
    Tanabe T; Shida D; Komukai S; Nakamura Y; Tsukamoto S; Kanemitsu Y
    BMC Cancer; 2019 Jul; 19(1):733. PubMed ID: 31340778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease?
    Akiyoshi T; Watanabe T; Miyata S; Kotake K; Muto T; Sugihara K;
    Ann Surg; 2012 Jun; 255(6):1129-34. PubMed ID: 22549752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesorectal excision with lateral lymph node dissection for mid-low rectal cancer with lateral lymph node metastasis: efficacy and prognostic analysis.
    Zhou S; Jiang Y; Liang J; Liu Q
    World J Surg Oncol; 2022 Mar; 20(1):97. PubMed ID: 35351137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-111 DTPA octreotide scintigraphy and intraoperative gamma probe detection in the diagnosis and treatment of residual lymph node metastases of a rectal carcinoid tumor.
    Banzo J; Vidal-Sicat S; Prats E; Galofré G; Razola P; Mañé S; Ubieto MA; Abós MD
    Clin Nucl Med; 2005 May; 30(5):308-11. PubMed ID: 15827397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer.
    Akasu T; Sugihara K; Moriya Y
    Ann Surg Oncol; 2009 Oct; 16(10):2779-86. PubMed ID: 19626377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212).
    Ito M; Kobayashi A; Fujita S; Mizusawa J; Kanemitsu Y; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y;
    Eur J Surg Oncol; 2018 Apr; 44(4):463-468. PubMed ID: 29428473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoscintigraphy in patients with primary rectal cancer: the role of total mesorectal excision for primary rectal cancer--a lymphoscintigraphic study.
    Sterk P; Keller L; Jochims H; Klein P; Stelzner F; Bruch HP; Markert U
    Int J Colorectal Dis; 2002 May; 17(3):137-42; discussion 143. PubMed ID: 12049306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.